Is Bombay Super Hyb overvalued or undervalued?

As of 26 September 2025, the valuation grade for Bombay Super Hyb has moved from very expensive to expensive. The company is currently considered overvalued based on its high valuation ratios, including a PE ratio of 50.07, an EV to EBITDA of 42.66, and a PEG ratio of 2.34. These figures indicate that the stock is trading at a significant premium compared to its earnings growth potential.
In comparison to its peers, Bombay Super Hyb's valuation stands out as notably high. For instance, Jain Irrigation, which is rated attractive, has a PE ratio of 110.1, while Indo US Bio-Tech, rated fair, has a PE of 14.77. The disparity in these ratios suggests that Bombay Super Hyb may not justify its current price in relation to its earnings and growth prospects. Additionally, the company's recent stock performance has been underwhelming, with a year-to-date return of -15.1%, contrasting with a positive return of 4.27% for the Sensex during the same period.